Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Mesa Laboratories (MLAB) Shares Outstanding (Weighted Average) (2016 - 2025)

Mesa Laboratories' Shares Outstanding (Weighted Average) history spans 16 years, with the latest figure at $5.5 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 1.68% to $5.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.5 million, a 1.68% increase, with the full-year FY2025 number at $5.4 million, up 0.65% from a year prior.
  • Shares Outstanding (Weighted Average) hit $5.5 million in Q4 2025 for Mesa Laboratories, roughly flat from $5.5 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for MLAB hit a ceiling of $5.5 million in Q4 2025 and a floor of $5.0 million in Q1 2021.
  • Historically, Shares Outstanding (Weighted Average) has averaged $5.3 million across 5 years, with a median of $5.4 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): grew 18.45% in 2021 and later increased 0.47% in 2024.
  • Tracing MLAB's Shares Outstanding (Weighted Average) over 5 years: stood at $5.2 million in 2021, then grew by 2.03% to $5.3 million in 2022, then rose by 0.84% to $5.4 million in 2023, then increased by 0.54% to $5.4 million in 2024, then rose by 1.68% to $5.5 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for MLAB at $5.5 million in Q4 2025, $5.5 million in Q3 2025, and $5.5 million in Q2 2025.